SCHEMBL30200780

SCHEMBL30200780

COC(=O)CCCCCS(=O)(=O)Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.54
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CA12 O43570 4/20 0.44
CA14 Q9ULX7 4/20 0.44
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
KAT2B Q92831 3/20 0.42
EPHX2 P34913 1/20 0.41
KMT2A Q03164 1/20 0.41
RECQL P46063 1/20 0.39
CA1 P00915 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1403393 1.00 TSHR (0.54) TSHRLMNAALDH1A1CA12CA14
SCHEMBL1403149 1.00 TSHR (0.54) TSHRLMNAALDH1A1CA12CA14
SCHEMBL19402824 0.98 TSHR (0.56) TSHRLMNAALDH1A1CA12CA14
SCHEMBL1098601 0.92 TSHR (0.58) TSHRLMNAALDH1A1CA12CA14
SCHEMBL25702196 0.86 TSHR (0.56) TSHRLMNAALDH1A1CA12CA14
SCHEMBL19784709 0.86 TSHR (0.56) TSHRLMNAALDH1A1CA12CA14
SCHEMBL19963063 0.84 TSHR (0.54) TSHRLMNAALDH1A1CA12CA14
SCHEMBL19963067 0.84 TSHR (0.54) TSHRLMNAALDH1A1CA12CA14
SCHEMBL25702220 0.84 TSHR (0.54) TSHRLMNAALDH1A1CA12CA14
SCHEMBL770916 0.83 TSHR (0.55) TSHRLMNAALDH1A1CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401729-A1 BCL-XL DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-24 EP disclosed
WO-2023044046-A1 BCL-XL DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-23 WO disclosed